152 related articles for article (PubMed ID: 36065456)
1. Covid-19 pandemic, firms' responses, and unemployment in the ASEAN-5.
Ardiyono SK
Econ Anal Policy; 2022 Dec; 76():337-372. PubMed ID: 36065456
[TBL] [Abstract][Full Text] [Related]
2. Financial performance of China's listed firms in presence of coronavirus: Evidence from corporate culture and corporate social responsibility.
Zheng F; Zhao Z; Sun Y; Khan YA
Curr Psychol; 2023; 42(11):8897-8918. PubMed ID: 34400856
[TBL] [Abstract][Full Text] [Related]
3. Lockdown, employment adjustment, and financial frictions.
Lastauskas P
Small Bus Econ (Dordr); 2022; 58(2):919-942. PubMed ID: 38624870
[TBL] [Abstract][Full Text] [Related]
4. The Asymmetric Impact of COVID-19: A Novel Approach to Quantifying Financial Distress across Industries.
Archanskaia E; Canton E; Hobza A; Nikolov P; Simons W
Eur Econ Rev; 2023 Jun; ():104509. PubMed ID: 37360582
[TBL] [Abstract][Full Text] [Related]
5. Firms' solidity before an exogenous shock: Covid-19 pandemic in Italy.
Costa S; Sallusti F; Vicarelli C; Zurlo D
Econ Anal Policy; 2022 Dec; 76():946-961. PubMed ID: 36277035
[TBL] [Abstract][Full Text] [Related]
6. How geopolitical risk affect firms' internationalization performance: Evidence from China.
Guo J
Heliyon; 2024 May; 10(9):e30152. PubMed ID: 38694047
[TBL] [Abstract][Full Text] [Related]
7. Sadder but Wiser: The Role of SARS Imprinting and Firms' Recovery During the COVID-19 Pandemic.
Yao H; Wang J; Bo Q; Li M
Front Psychol; 2022; 13():917337. PubMed ID: 35756304
[TBL] [Abstract][Full Text] [Related]
8. How can artificial intelligence boost firms' exports? evidence from China.
Zhang Z; Deng F
PLoS One; 2023; 18(8):e0283230. PubMed ID: 37611039
[TBL] [Abstract][Full Text] [Related]
9. Fiscal Stimulus and Firms' Sales and Capital Expenditure During the Global Financial Crisis.
Correa-Caro C; Medina L; Poplawski-Ribeiro M; Sutton B
Comp Econ Stud; 2021; 63(3):489-535. PubMed ID: 34366561
[TBL] [Abstract][Full Text] [Related]
10. Firms' responses to the COVID-19 pandemic.
Klöckner M; Schmidt CG; Wagner SM; Swink M
J Bus Res; 2023 Mar; 158():113664. PubMed ID: 36685011
[TBL] [Abstract][Full Text] [Related]
11. Green management, access to credit, and firms' vulnerability to the COVID-19 crisis.
Aristei D; Gallo M
Small Bus Econ (Dordr); 2023 Apr; ():1-33. PubMed ID: 38625207
[TBL] [Abstract][Full Text] [Related]
12. The impact of COVID-19 on the valuations of non-financial European firms.
Abbas Rizvi SK; Yarovaya L; Mirza N; Naqvi B
Heliyon; 2022 Jun; 8(6):e09486. PubMed ID: 35634174
[TBL] [Abstract][Full Text] [Related]
13. The impact of COVID-19 on Japanese firms: mobility and resilience via remote work.
Kawaguchi D; Kitao S; Nose M
Int Tax Public Financ; 2022; 29(6):1419-1449. PubMed ID: 36092538
[TBL] [Abstract][Full Text] [Related]
14. Firms' COVID-19 Pandemic Exposure and Corporate Cash Policy: Evidence from China.
He Z; Suardi S; Wang K; Zhao Y
Econ Model; 2022 Nov; 116():105999. PubMed ID: 36032988
[TBL] [Abstract][Full Text] [Related]
15. Investing for keeps: Firms' prepandemic investments in human capital decreased workforce reductions associated with COVID-19 financial pressures.
Bentley FS; Kehoe RR; Chung H
J Appl Psychol; 2021 Dec; 106(12):1785-1804. PubMed ID: 34968090
[TBL] [Abstract][Full Text] [Related]
16. Firms' challenges and social responsibilities during Covid-19: A Twitter analysis.
Patuelli A; Caldarelli G; Lattanzi N; Saracco F
PLoS One; 2021; 16(7):e0254748. PubMed ID: 34314432
[TBL] [Abstract][Full Text] [Related]
17. The role of capital structure management in maintaining the financial stability of hotel firms during the pandemic-A global investigation.
Thi Mai Nguyen L; Le D; Vu KT; Tran TK
Int J Hosp Manag; 2023 Feb; 109():103366. PubMed ID: 36447774
[TBL] [Abstract][Full Text] [Related]
18. Investors' reactions and firms' actions in the Covid-19 period: The case of Taiwan.
Hsu J; Young W; Huang YW
Int Rev Financ Anal; 2021 Nov; 78():101905. PubMed ID: 36532658
[TBL] [Abstract][Full Text] [Related]
19. Unveiling the Effectiveness of Agency Cost and Firms' Size as Moderators Between CSR Disclosure and Firms' Growth.
Akram A; Tang Y; Tariq J
Front Psychol; 2020; 11():1624. PubMed ID: 32903572
[TBL] [Abstract][Full Text] [Related]
20. Firm-level short selling and the local COVID-19 pandemic: Evidence from China.
He J; Ma X; Wei Q
Econ Model; 2022 Aug; 113():105896. PubMed ID: 35578633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
